1-3 of 3
Michael J. Hansen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells

Available to Purchase
R. Leo Sakemura, Mehrdad Hefazi, Michelle J. Cox, Elizabeth L. Siegler, Sutapa Sinha, Michael J. Hansen, Carli M. Stewart, Jennifer M. Feigin, Claudia Manriquez Roman, Kendall J. Schick, Ismail Can, Erin E. Tapper, Paulina Horvei, Mohamad M. Adada, Evandro D. Bezerra, Lionel Aurelien Kankeu Fonkoua, Michael W. Ruff, Cynthia L. Forsman, Wendy K. Nevala, Justin C. Boysen, Renee C. Tschumper, Cory L. Grand, Kameswara R. Kuchimanchi, Lars Mouritsen, Jason M. Foulks, Steven L. Warner, Timothy G. Call, Sameer A. Parikh, Wei Ding, Neil E. Kay, Saad S. Kenderian
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (9): 1222–1236.
https://doi.org/10.1158/2326-6066.CIR-22-0254
Published: 01 September 2023
View articletitled, AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells
Open the PDF for AXL Inhibition Improves the Antitumor Activity of Chimeric Antigen Receptor T Cells in another window
Includes: Supplementary data
Journal Articles

Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression

Available to Purchase
Zachariah P. Tritz, Katayoun Ayasoufi, Delaney M. Wolf, Carley A. Owens, Courtney S. Malo, Benjamin T. Himes, Cori E. Fain, Emma N. Goddery, Lila T. Yokanovich, Fang Jin, Michael J. Hansen, Ian F. Parney, Chensu Wang, Kelly D. Moynihan, Darrell J. Irvine, K. Dane Wittrup, Rosa M. Diaz Marcano, Richard G. Vile, Aaron J. Johnson
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (6): 763–776.
https://doi.org/10.1158/2326-6066.CIR-22-0570
Published: 02 June 2023
View articletitled, Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression
Open the PDF for Anti–PD-1 and Extended Half-life IL2 Synergize for Treatment of Murine Glioblastoma Independent of Host MHC Class I Expression in another window
Includes: Supplementary data
Journal Articles

Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity

Available to Purchase
Reona Sakemura, Aditya Bansal, Elizabeth L. Siegler, Mehrdad Hefazi, Nan Yang, Roman H. Khadka, Alysha N. Newsom, Michael J. Hansen, Michelle J. Cox, Claudia Manriquez Roman, Kendall J. Schick, Ismail Can, Erin E. Tapper, Wendy K. Nevala, Mohamad M. Adada, Evandro D. Bezerra, Lionel Aurelien Kankeu Fonkoua, Paulina Horvei, Michael W. Ruff, Sameer A. Parikh, Mukesh K. Pandey, Timothy R. DeGrado, Lukkana Suksanpaisan, Neil E. Kay, Kah-Whye Peng, Stephen J. Russell, Saad S. Kenderian
Journal: Cancer Immunology Research
Cancer Immunol Res (2021) 9 (9): 1035–1046.
https://doi.org/10.1158/2326-6066.CIR-20-0901
Published: 01 September 2021
View articletitled, Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity
Open the PDF for Development of a Clinically Relevant Reporter for Chimeric Antigen Receptor T-cell Expansion, Trafficking, and Toxicity in another window
Includes: Supplementary data